Universal Electronics Reports Fourth Quarter and Year-End 2022 Financial Results
Feb 16, 2023
|
“During the past 18 months, we have won a significant number of large customer design projects in our new higher growth markets and, at CES in
UEI’s CFO
Financial Results for the Three Months Ended
-
GAAP net sales were
$122.8 million , compared to$144.9 million ; Adjusted Non-GAAP net sales were$122.8 million , compared to$143.9 million . - GAAP gross margins were 26.2%, compared to 24.9%; Adjusted Non-GAAP gross margins were 30.7%, compared to 28.4%.
-
GAAP operating loss was
$1.9 million , compared to$3.3 million ; Adjusted Non-GAAP operating income was$8.3 million , compared to$10.7 million . -
GAAP net loss was
$6.9 million , or$0.54 per share, compared to$6.3 million , or$0.49 per share; Adjusted Non-GAAP net income was$5.6 million , or$0.44 per diluted share, compared to$9.0 million , or$0.68 per diluted share. -
At
December 31, 2022 , cash and cash equivalents were$66.7 million .
Financial Results for the Twelve Months Ended
-
GAAP net sales were
$542.8 million , compared to$601.6 million ; Adjusted Non-GAAP net sales were$542.8 million , compared to$600.9 million . - GAAP gross margins were 28.1%, compared to 28.8%; Adjusted Non-GAAP gross margins were 29.9%, compared to 30.2%.
-
GAAP operating income was
$14.5 million , compared to$23.3 million ; Adjusted Non-GAAP operating income was$41.8 million , compared to$58.9 million . -
GAAP net income was
$0.4 million , or$0.03 per diluted share, compared to$5.3 million , or$0.39 per diluted share; Adjusted Non-GAAP net income was$32.7 million , or$2.56 per diluted share, compared to$49.4 million , or$3.59 per diluted share.
Financial Outlook
For the first quarter of 2023, the company expects GAAP net sales to range between
For the first quarter of 2023, the company expects Adjusted Non-GAAP net sales to range between
Conference Call Information
UEI’s management team will hold a conference call today,
Use of Non-GAAP Financial Metrics
In addition to reporting financial results in accordance with generally accepted accounting principles, or GAAP, UEI provides Adjusted Non-GAAP information as additional information for its operating results. References to Adjusted Non-GAAP information are to non-GAAP financial measures. These measures are not required by, in accordance with, or an alternative for, GAAP and may be different from non-GAAP financial measures used by other companies. UEI’s management uses these measures for reviewing the financial results of UEI for budget planning purposes and for making operational and financial decisions. Management believes that providing these non-GAAP financial measures to investors, as a supplement to GAAP financial measures, help investors evaluate UEI’s core operating and financial performance and business trends consistent with how management evaluates such performance and trends. Additionally, management believes these measures facilitate comparisons with the core operating and financial results and business trends of competitors and other companies.
Adjusted Non-GAAP net sales is defined as net sales excluding the revenue impact of stock-based compensation for performance-based warrants. Adjusted Non-GAAP gross profit is defined as gross profit excluding the impact of excess manufacturing overhead costs, factory transition costs, impairment charges on fixed assets, gain on the release from our
About
Forward-looking Statements
This press release and accompanying schedules contain "forward-looking statements" within the meaning of federal securities laws, including net sales, profit margin and earnings trends, estimates and assumptions; our expectations about new product introductions; and similar statements concerning anticipated future events and expectations that are not historical facts. We caution you that these statements are not guarantees of future performance and are subject to numerous risks and uncertainties, including those we identify below and other risk factors that we identify in our annual report on Form 10-K for the year ended
|
||||||||
CONSOLIDATED BALANCE SHEETS |
||||||||
(In thousands, except share-related data) |
||||||||
(Unaudited) |
||||||||
|
|
|
|
|
||||
ASSETS |
|
|
|
|
||||
Current assets: |
|
|
|
|
||||
Cash and cash equivalents |
|
$ |
66,740 |
|
|
$ |
60,813 |
|
Accounts receivable, net |
|
|
112,346 |
|
|
|
129,215 |
|
Contract assets |
|
|
7,996 |
|
|
|
5,012 |
|
Inventories |
|
|
140,181 |
|
|
|
134,469 |
|
Prepaid expenses and other current assets |
|
|
6,647 |
|
|
|
7,289 |
|
Income tax receivable |
|
|
4,130 |
|
|
|
348 |
|
Total current assets |
|
|
338,040 |
|
|
|
337,146 |
|
Property, plant and equipment, net |
|
|
62,791 |
|
|
|
74,647 |
|
|
|
|
49,085 |
|
|
|
48,463 |
|
Intangible assets, net |
|
|
24,470 |
|
|
|
20,169 |
|
Operating lease right-of-use assets |
|
|
21,599 |
|
|
|
19,847 |
|
Deferred income taxes |
|
|
6,242 |
|
|
|
7,729 |
|
Other assets |
|
|
1,936 |
|
|
|
2,347 |
|
Total assets |
|
$ |
504,163 |
|
|
$ |
510,348 |
|
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
|
|
||||
Current liabilities: |
|
|
|
|
||||
Accounts payable |
|
$ |
71,373 |
|
|
$ |
92,707 |
|
Line of credit |
|
|
88,000 |
|
|
|
56,000 |
|
Accrued compensation |
|
|
20,904 |
|
|
|
24,217 |
|
Accrued sales discounts, rebates and royalties |
|
|
6,477 |
|
|
|
9,286 |
|
Accrued income taxes |
|
|
5,585 |
|
|
|
3,737 |
|
Other accrued liabilities |
|
|
24,134 |
|
|
|
30,840 |
|
Total current liabilities |
|
|
216,473 |
|
|
|
216,787 |
|
Long-term liabilities: |
|
|
|
|
||||
Operating lease obligations |
|
|
15,027 |
|
|
|
14,266 |
|
Deferred income taxes |
|
|
2,724 |
|
|
|
2,394 |
|
Income tax payable |
|
|
723 |
|
|
|
939 |
|
Other long-term liabilities |
|
|
810 |
|
|
|
13 |
|
Total liabilities |
|
|
235,757 |
|
|
|
234,399 |
|
Commitments and contingencies |
|
|
|
|
||||
Stockholders’ equity: |
|
|
|
|
||||
Preferred stock, |
|
|
— |
|
|
|
— |
|
Common stock, |
|
|
250 |
|
|
|
247 |
|
Paid-in capital |
|
|
326,839 |
|
|
|
314,094 |
|
|
|
|
(368,194 |
) |
|
|
(355,159 |
) |
Accumulated other comprehensive income (loss) |
|
|
(21,187 |
) |
|
|
(13,524 |
) |
Retained earnings |
|
|
330,698 |
|
|
|
330,291 |
|
Total stockholders’ equity |
|
|
268,406 |
|
|
|
275,949 |
|
Total liabilities and stockholders’ equity |
|
$ |
504,163 |
|
|
$ |
510,348 |
|
|
||||||||||||||||
CONSOLIDATED INCOME STATEMENTS |
||||||||||||||||
(In thousands, except per share amounts) |
||||||||||||||||
(Unaudited) |
||||||||||||||||
|
|
Three Months Ended |
|
Twelve Months Ended |
||||||||||||
|
|
|
2022 |
|
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
Net sales |
|
$ |
122,758 |
|
|
$ |
144,944 |
|
|
$ |
542,751 |
|
|
$ |
601,602 |
|
Cost of sales |
|
|
90,547 |
|
|
|
108,809 |
|
|
|
390,459 |
|
|
|
428,586 |
|
Gross profit |
|
|
32,211 |
|
|
|
36,135 |
|
|
|
152,292 |
|
|
|
173,016 |
|
Research and development expenses |
|
|
7,992 |
|
|
|
7,888 |
|
|
|
32,452 |
|
|
|
30,917 |
|
Selling, general and administrative expenses |
|
|
26,104 |
|
|
|
31,530 |
|
|
|
105,292 |
|
|
|
118,846 |
|
Operating income (loss) |
|
|
(1,885 |
) |
|
|
(3,283 |
) |
|
|
14,548 |
|
|
|
23,253 |
|
Interest income (expense), net |
|
|
(1,053 |
) |
|
|
(119 |
) |
|
|
(2,200 |
) |
|
|
(566 |
) |
Loss on sale of |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(6,050 |
) |
Other income (expense), net |
|
|
(567 |
) |
|
|
(406 |
) |
|
|
(955 |
) |
|
|
(557 |
) |
Income (loss) before provision for income taxes |
|
|
(3,505 |
) |
|
|
(3,808 |
) |
|
|
11,393 |
|
|
|
16,080 |
|
Provision for income taxes |
|
|
3,400 |
|
|
|
2,522 |
|
|
|
10,986 |
|
|
|
10,779 |
|
Net income (loss) |
|
$ |
(6,905 |
) |
|
$ |
(6,330 |
) |
|
$ |
407 |
|
|
$ |
5,301 |
|
|
|
|
|
|
|
|
|
|
||||||||
Earnings (loss) per share: |
|
|
|
|
|
|
||||||||||
Basic |
|
$ |
(0.54 |
) |
|
$ |
(0.49 |
) |
|
$ |
0.03 |
|
|
$ |
0.39 |
|
Diluted |
|
$ |
(0.54 |
) |
|
$ |
(0.49 |
) |
|
$ |
0.03 |
|
|
$ |
0.39 |
|
Shares used in computing earnings (loss) per share: |
|
|
|
|
|
|
|
|
||||||||
Basic |
|
|
12,686 |
|
|
|
13,000 |
|
|
|
12,703 |
|
|
|
13,465 |
|
Diluted |
|
|
12,686 |
|
|
|
13,000 |
|
|
|
12,779 |
|
|
|
13,742 |
|
|
||||||||
CONSOLIDATED STATEMENTS OF CASH FLOWS |
||||||||
(In thousands) |
||||||||
(Unaudited) |
||||||||
|
|
Year Ended |
||||||
|
|
|
2022 |
|
|
|
2021 |
|
Cash flows from operating activities: |
|
|
|
|
||||
Net income |
|
$ |
407 |
|
|
$ |
5,301 |
|
Adjustments to reconcile net income to net cash provided by (used for) operating activities: |
|
|
|
|
||||
Depreciation and amortization |
|
|
24,033 |
|
|
|
26,747 |
|
Provision for credit losses |
|
|
(182 |
) |
|
|
— |
|
Deferred income taxes |
|
|
1,377 |
|
|
|
(1,560 |
) |
Shares issued for employee benefit plan |
|
|
1,199 |
|
|
|
1,092 |
|
Employee and director stock-based compensation |
|
|
10,013 |
|
|
|
9,969 |
|
Performance-based common stock warrants |
|
|
— |
|
|
|
(686 |
) |
Impairment of long-term assets |
|
|
2,888 |
|
|
|
3,338 |
|
Loss on sale of |
|
|
— |
|
|
|
5,960 |
|
Changes in operating assets and liabilities: |
|
|
|
|
||||
Accounts receivable and contract assets |
|
|
12,765 |
|
|
|
2,007 |
|
Inventories |
|
|
(9,913 |
) |
|
|
(14,985 |
) |
Prepaid expenses and other assets |
|
|
(917 |
) |
|
|
(630 |
) |
Accounts payable and accrued liabilities |
|
|
(28,670 |
) |
|
|
870 |
|
Accrued income taxes |
|
|
(2,074 |
) |
|
|
2,860 |
|
Net cash provided by (used for) operating activities |
|
|
10,926 |
|
|
|
40,283 |
|
Cash flows from investing activities: |
|
|
|
|
||||
Purchase of term deposit |
|
|
(7,487 |
) |
|
|
— |
|
Redemption of term deposit |
|
|
7,803 |
|
|
|
— |
|
Acquisition of net assets of |
|
|
(939 |
) |
|
|
— |
|
Acquisitions of property, plant and equipment |
|
|
(14,006 |
) |
|
|
(12,586 |
) |
Acquisitions of intangible assets |
|
|
(6,579 |
) |
|
|
(4,455 |
) |
Net cash provided by (used for) investing activities |
|
|
(21,208 |
) |
|
|
(17,041 |
) |
Cash flows from financing activities: |
|
|
|
|
||||
Borrowings under line of credit |
|
|
133,000 |
|
|
|
112,000 |
|
Repayments on line of credit |
|
|
(101,000 |
) |
|
|
(76,000 |
) |
Proceeds from stock options exercised |
|
|
1,536 |
|
|
|
1,638 |
|
|
|
|
(13,035 |
) |
|
|
(59,664 |
) |
Net cash provided by (used for) financing activities |
|
|
20,501 |
|
|
|
(22,026 |
) |
Effect of foreign currency exchange rates on cash and cash equivalents |
|
|
(4,292 |
) |
|
|
2,444 |
|
Net increase (decrease) in cash and cash equivalents |
|
|
5,927 |
|
|
|
3,660 |
|
Cash and cash equivalents at beginning of period |
|
|
60,813 |
|
|
|
57,153 |
|
Cash and cash equivalents at end of period |
|
$ |
66,740 |
|
|
$ |
60,813 |
|
|
|
|
|
|
||||
Supplemental cash flow information: |
|
|
|
|
||||
Income taxes paid |
|
$ |
10,922 |
|
|
$ |
10,093 |
|
Interest paid |
|
$ |
2,214 |
|
|
$ |
620 |
|
|
||||||||||||||||
RECONCILIATION OF ADJUSTED NON-GAAP FINANCIAL RESULTS |
||||||||||||||||
(In thousands, except per share amounts) |
||||||||||||||||
(Unaudited) |
||||||||||||||||
|
|
Three Months Ended |
|
Twelve Months Ended |
||||||||||||
|
|
|
2022 |
|
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
Net sales: |
|
|
|
|
|
|
|
|
||||||||
Net sales - GAAP |
|
$ |
122,758 |
|
|
$ |
144,944 |
|
|
$ |
542,751 |
|
|
$ |
601,602 |
|
Stock-based compensation for performance-based warrants |
|
|
— |
|
|
|
(1,084 |
) |
|
|
— |
|
|
|
(686 |
) |
Adjusted Non-GAAP net sales |
|
$ |
122,758 |
|
|
$ |
143,860 |
|
|
$ |
542,751 |
|
|
$ |
600,916 |
|
|
|
|
|
|
|
|
|
|
||||||||
Cost of sales: |
|
|
|
|
|
|
|
|
||||||||
Cost of sales - GAAP |
|
$ |
90,547 |
|
|
$ |
108,809 |
|
|
$ |
390,459 |
|
|
$ |
428,586 |
|
Excess manufacturing overhead and factory transition costs (1) |
|
|
(2,549 |
) |
|
|
(2,262 |
) |
|
|
(6,670 |
) |
|
|
(5,830 |
) |
Impairment of fixed assets (2) |
|
|
(2,868 |
) |
|
|
(3,473 |
) |
|
|
(2,868 |
) |
|
|
(3,473 |
) |
Gain on release from |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
542 |
|
Stock-based compensation expense |
|
|
(38 |
) |
|
|
(40 |
) |
|
|
(155 |
) |
|
|
(156 |
) |
Adjustments to acquired tangible assets (4) |
|
|
(60 |
) |
|
|
(63 |
) |
|
|
(241 |
) |
|
|
(257 |
) |
Adjusted Non-GAAP cost of sales |
|
|
85,032 |
|
|
|
102,971 |
|
|
|
380,525 |
|
|
|
419,412 |
|
Adjusted Non-GAAP gross profit |
|
$ |
37,726 |
|
|
$ |
40,889 |
|
|
$ |
162,226 |
|
|
$ |
181,504 |
|
|
|
|
|
|
|
|
|
|
||||||||
Gross margin: |
|
|
|
|
|
|
|
|
||||||||
Gross margin - GAAP |
|
|
26.2 |
% |
|
|
24.9 |
% |
|
|
28.1 |
% |
|
|
28.8 |
% |
Stock-based compensation for performance-based warrants |
|
|
— |
% |
|
|
(0.5 |
)% |
|
|
— |
% |
|
|
(0.1 |
)% |
Excess manufacturing overhead and factory transition costs (1) |
|
|
2.1 |
% |
|
|
1.6 |
% |
|
|
1.2 |
% |
|
|
1.0 |
% |
Impairment of fixed assets (2) |
|
|
2.3 |
% |
|
|
2.4 |
% |
|
|
0.5 |
% |
|
|
0.6 |
% |
Gain on release from |
|
|
— |
% |
|
|
— |
% |
|
|
— |
% |
|
|
(0.1 |
)% |
Stock-based compensation expense |
|
|
0.0 |
% |
|
|
0.0 |
% |
|
|
0.0 |
% |
|
|
0.0 |
% |
Adjustments to acquired tangible assets (4) |
|
|
0.1 |
% |
|
|
0.0 |
% |
|
|
0.1 |
% |
|
|
0.0 |
% |
Adjusted Non-GAAP gross margin |
|
|
30.7 |
% |
|
|
28.4 |
% |
|
|
29.9 |
% |
|
|
30.2 |
% |
|
|
|
|
|
|
|
|
|
||||||||
Operating expenses: |
|
|
|
|
|
|
|
|
||||||||
Operating expenses - GAAP |
|
$ |
34,096 |
|
|
$ |
39,418 |
|
|
$ |
137,744 |
|
|
$ |
149,763 |
|
Stock-based compensation expense |
|
|
(2,401 |
) |
|
|
(2,414 |
) |
|
|
(9,858 |
) |
|
|
(9,814 |
) |
Amortization of acquired intangible assets |
|
|
(281 |
) |
|
|
(714 |
) |
|
|
(1,153 |
) |
|
|
(1,544 |
) |
Change in contingent consideration |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
180 |
|
Litigation costs (5) |
|
|
(2,004 |
) |
|
|
(5,294 |
) |
|
|
(6,268 |
) |
|
|
(15,300 |
) |
Employee related restructuring and other costs |
|
|
— |
|
|
|
(828 |
) |
|
|
— |
|
|
|
(717 |
) |
Adjusted Non-GAAP operating expenses |
|
$ |
29,410 |
|
|
$ |
30,168 |
|
|
$ |
120,465 |
|
|
$ |
122,568 |
|
|
||||||||||||||||
RECONCILIATION OF ADJUSTED NON-GAAP FINANCIAL RESULTS |
||||||||||||||||
(In thousands, except per share amounts) |
||||||||||||||||
(Unaudited) |
||||||||||||||||
|
|
Three Months Ended |
|
Twelve Months Ended |
||||||||||||
|
|
|
2022 |
|
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
Operating income (loss): |
|
|
|
|
|
|
|
|
||||||||
Operating income (loss) - GAAP |
|
$ |
(1,885 |
) |
|
$ |
(3,283 |
) |
|
$ |
14,548 |
|
|
$ |
23,253 |
|
Stock-based compensation for performance-based warrants |
|
|
— |
|
|
|
(1,084 |
) |
|
|
— |
|
|
|
(686 |
) |
Excess manufacturing overhead and factory transition costs (1) |
|
|
2,549 |
|
|
|
2,262 |
|
|
|
6,670 |
|
|
|
5,830 |
|
Impairment of fixed assets (2) |
|
|
2,868 |
|
|
|
3,473 |
|
|
|
2,868 |
|
|
|
3,473 |
|
Gain on release from |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(542 |
) |
Stock-based compensation expense |
|
|
2,439 |
|
|
|
2,454 |
|
|
|
10,013 |
|
|
|
9,970 |
|
Adjustments to acquired tangible assets (4) |
|
|
60 |
|
|
|
63 |
|
|
|
241 |
|
|
|
257 |
|
Amortization of acquired intangible assets |
|
|
281 |
|
|
|
714 |
|
|
|
1,153 |
|
|
|
1,544 |
|
Change in contingent consideration |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(180 |
) |
Litigation costs (5) |
|
|
2,004 |
|
|
|
5,294 |
|
|
|
6,268 |
|
|
|
15,300 |
|
Employee related restructuring and other costs |
|
|
— |
|
|
|
828 |
|
|
|
— |
|
|
|
717 |
|
Adjusted Non-GAAP operating income |
|
$ |
8,316 |
|
|
$ |
10,721 |
|
|
$ |
41,761 |
|
|
$ |
58,936 |
|
|
|
|
|
|
|
|
|
|
||||||||
Adjusted Non-GAAP operating income as a percentage of net sales |
|
|
6.8 |
% |
|
|
7.5 |
% |
|
|
7.7 |
% |
|
|
9.8 |
% |
|
|
|
|
|
|
|
|
|
||||||||
Net income (loss): |
|
|
|
|
|
|
|
|
||||||||
Net income (loss) - GAAP |
|
$ |
(6,905 |
) |
|
$ |
(6,330 |
) |
|
$ |
407 |
|
|
$ |
5,301 |
|
Stock-based compensation for performance-based warrants |
|
|
— |
|
|
|
(1,084 |
) |
|
|
— |
|
|
|
(686 |
) |
Excess manufacturing overhead and factory transition costs (1) |
|
|
2,549 |
|
|
|
2,262 |
|
|
|
6,670 |
|
|
|
5,830 |
|
Impairment of fixed assets (2) |
|
|
2,868 |
|
|
|
3,473 |
|
|
|
2,868 |
|
|
|
3,473 |
|
Gain on release from |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(542 |
) |
Stock-based compensation expense |
|
|
2,439 |
|
|
|
2,454 |
|
|
|
10,013 |
|
|
|
9,970 |
|
Adjustments to acquired tangible assets (4) |
|
|
60 |
|
|
|
63 |
|
|
|
241 |
|
|
|
257 |
|
Amortization of acquired intangible assets |
|
|
281 |
|
|
|
714 |
|
|
|
1,153 |
|
|
|
1,544 |
|
Change in contingent consideration |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(180 |
) |
Litigation costs (5) |
|
|
2,004 |
|
|
|
5,294 |
|
|
|
6,268 |
|
|
|
15,300 |
|
Employee related restructuring and other costs |
|
|
— |
|
|
|
828 |
|
|
|
— |
|
|
|
717 |
|
Loss on sale of |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
6,050 |
|
Foreign currency (gain) loss |
|
|
1,075 |
|
|
|
579 |
|
|
|
1,091 |
|
|
|
1,334 |
|
Income tax provision on adjustments |
|
|
1,277 |
|
|
|
789 |
|
|
|
4,035 |
|
|
|
984 |
|
Adjusted Non-GAAP net income |
|
$ |
5,648 |
|
|
$ |
9,042 |
|
|
$ |
32,746 |
|
|
$ |
49,352 |
|
|
|
|
|
|
|
|
|
|
||||||||
Diluted shares used in computing earnings (loss) per share: |
|
|
|
|
|
|
|
|
||||||||
GAAP |
|
|
12,686 |
|
|
|
13,000 |
|
|
|
12,779 |
|
|
|
13,742 |
|
Adjusted Non-GAAP |
|
|
12,729 |
|
|
|
13,214 |
|
|
|
12,779 |
|
|
|
13,742 |
|
|
|
|
|
|
|
|
|
|
||||||||
Diluted earnings (loss) per share: |
|
|
|
|
|
|
|
|
||||||||
Diluted earnings (loss) per share - GAAP |
|
$ |
(0.54 |
) |
|
$ |
(0.49 |
) |
|
$ |
0.03 |
|
|
$ |
0.39 |
|
Total adjustments |
|
$ |
0.99 |
|
|
$ |
1.16 |
|
|
$ |
2.53 |
|
|
$ |
3.21 |
|
Adjusted Non-GAAP diluted earnings per share |
|
$ |
0.44 |
|
|
$ |
0.68 |
|
|
$ |
2.56 |
|
|
$ |
3.59 |
|
(1) |
The three and twelve months ended |
|
(2) |
The three and twelve months ended |
|
(3) |
Consists of the gain associated with the |
|
(4) |
Consists of depreciation related to the mark-up from cost to fair value of fixed assets acquired in business combinations. |
|
(5) |
Consists of expenses related to our various litigation matters involving Roku, Inc. and certain other related entities including three |
|
(6) |
Consists of the loss recorded on the sale of our |
|
||||||||||||
RECONCILIATION OF ADJUSTED NON-GAAP FINANCIAL OUTLOOK AND FINANCIAL RESULTS |
||||||||||||
(In thousands, except per share amounts) |
||||||||||||
(Unaudited) |
||||||||||||
|
|
Three Months Ended |
||||||||||
|
|
2023 |
|
2022 |
||||||||
|
|
|
|
|
|
Actual |
||||||
Net sales: |
|
|
|
|
|
|
||||||
Net sales - GAAP |
|
$ |
100,000 |
|
|
$ |
110,000 |
|
|
$ |
132,410 |
|
Total adjustments (1) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Adjusted Non-GAAP net sales |
|
$ |
100,000 |
|
|
$ |
110,000 |
|
|
$ |
132,410 |
|
|
|
|
|
|
|
|
||||||
Diluted earnings (loss) per share: |
|
|
|
|
|
|
||||||
Loss per share - GAAP |
|
$ |
(1.21 |
) |
|
$ |
(1.11 |
) |
|
$ |
(0.23 |
) |
Total adjustments (2) |
|
$ |
0.83 |
|
|
$ |
0.83 |
|
|
$ |
0.69 |
|
Adjusted Non-GAAP diluted earnings (loss) per share |
|
$ |
(0.38 |
) |
|
$ |
(0.28 |
) |
|
$ |
0.47 |
|
(1) |
The three months ended |
|
(2) |
The three months ended |
View source version on businesswire.com: https://www.businesswire.com/news/home/20230216005778/en/
Investors:
Source: